Therapeutic effect of repetitive transcranial magnetic stimulation in end stage renal disease patients with major depressive disorder

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0004082

Enrollment

Registered

2019-06-20

Start date

2017-04-18

Completion date

Unknown

Last updated

2019-07-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : The rTMS group was stimulated with a 110&#37

motor threshold and 10 hertz on the left dorsolateral prefrontal cortex for 20 minutes, three times a week, for four weeks. In sham group, the “1-wing 90 degree method” was used to prevent the effecti

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Diagnosis with end-stage renal disease (ESRD) and currently receiving maintenance hemodialysis. 2. A score of 5 or more on Patient health Questionnair-9

Exclusion criteria

Exclusion criteria: 1. Diagnosis with major psychiatric disorders other than major depressive disorder 2. Conductive metal around the head 3. Current use of anticonvulsant drugs or other psychiatirc drugs within the past month 4. Left handed 5. History of epilepsy, head trauma, or neurocognitive disorder 6. Current pregnant state

Design outcomes

Primary

Measure	Time frame
laboratory data(Hb/Hct, BUN/Creatinine, Ca/P/K, Total cholesterol, albumin, iron/TIBC, ferritin, intact PTH, Glucose, HbA1C)	—

Secondary

Measure	Time frame
quantitative electroencephalogram;psychiatric questionnaires(Beck's depression index-II, Beck's anxiety index , SCL-90R-Somatization subscales, Perceived Stress Scale)	—

Countries

Korea, Republic of

Contacts

Public ContactJin Ho Hwang

Chung-Ang Univerisity Hospital

dennyjinho@gmail.com+82-2-6299-1455

Outcome results